- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.35 Å
- Oligo State
- hetero-2-2-mer
- Ligands
- 2 x AX7: 1H-benzimidazol-2-amine(Non-covalent)
- 7 x MG: MAGNESIUM ION(Non-covalent)(Non-functional Binders)
MG.2: 3 residues within 4Å:- Chain A: E.259
- Chain B: D.176, E.480
5 PLIP interactions:1 interactions with chain B, 1 interactions with chain A, 3 Ligand-Water interactions- Metal complexes: B:E.480, A:E.259, H2O.5, H2O.7, H2O.9
MG.23: 3 residues within 4Å:- Chain C: U.8, A.9, U.12
No protein-ligand interaction detected (PLIP)MG.24: 1 residues within 4Å:- Chain C: G.46
No protein-ligand interaction detected (PLIP)MG.25: 1 residues within 4Å:- Chain C: A.38
No protein-ligand interaction detected (PLIP)MG.26: 3 residues within 4Å:- Chain C: C.30, G.42, G.43
No protein-ligand interaction detected (PLIP)MG.28: 4 residues within 4Å:- Chain D: E.259
- Chain E: D.176, D.471, E.480
6 PLIP interactions:1 interactions with chain D, 1 interactions with chain E, 4 Ligand-Water interactions- Metal complexes: D:E.259, E:E.480, H2O.19, H2O.21, H2O.21, H2O.23
MG.39: 1 residues within 4Å:- Chain F: G.31
No protein-ligand interaction detected (PLIP)- 16 x ACT: ACETATE ION(Non-functional Binders)
ACT.3: 8 residues within 4Å:- Chain A: P.105, A.106, G.107, V.339
- Chain B: A.519, L.520, G.522
- Chain E: R.668
Ligand excluded by PLIPACT.4: 4 residues within 4Å:- Chain A: A.236, R.239
- Chain E: A.500, G.501
Ligand excluded by PLIPACT.5: 3 residues within 4Å:- Chain B: R.82, Q.83, Y.84
Ligand excluded by PLIPACT.7: 6 residues within 4Å:- Chain B: R.36, I.37, A.193, R.484, L.485, G.487
Ligand excluded by PLIPACT.8: 4 residues within 4Å:- Chain A: V.104
- Chain B: L.520
- Chain D: V.104
- Chain E: L.520
Ligand excluded by PLIPACT.11: 5 residues within 4Å:- Chain B: I.45, L.47, N.136, L.137, G.138
Ligand excluded by PLIPACT.12: 6 residues within 4Å:- Chain B: G.160, V.161, G.163, W.246, R.250
- Ligands: EPE.19
Ligand excluded by PLIPACT.13: 5 residues within 4Å:- Chain B: W.540, L.682, A.708, R.712
- Chain D: D.86
Ligand excluded by PLIPACT.14: 4 residues within 4Å:- Chain B: L.196, D.197, F.198, Q.449
Ligand excluded by PLIPACT.15: 5 residues within 4Å:- Chain B: P.215, A.216, W.217, P.218
- Ligands: ACT.16
Ligand excluded by PLIPACT.16: 4 residues within 4Å:- Chain B: W.217, P.218, G.288
- Ligands: ACT.15
Ligand excluded by PLIPACT.22: 3 residues within 4Å:- Chain C: C.26, G.27, U.28
Ligand excluded by PLIPACT.29: 7 residues within 4Å:- Chain B: R.668
- Chain D: T.102, V.104, P.105, A.106, G.107, V.339
Ligand excluded by PLIPACT.33: 4 residues within 4Å:- Chain E: Q.440, G.441, T.442, R.445
Ligand excluded by PLIPACT.34: 3 residues within 4Å:- Chain E: L.196, F.198, Q.449
Ligand excluded by PLIPACT.35: 4 residues within 4Å:- Chain E: Q.788, L.833, R.834, G.835
Ligand excluded by PLIP- 8 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.6: 4 residues within 4Å:- Chain B: D.431, G.435, V.436, A.437
No protein-ligand interaction detected (PLIP)EDO.17: 4 residues within 4Å:- Chain B: V.753, Q.788, R.834, G.835
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:G.835, B:G.835
EDO.18: 5 residues within 4Å:- Chain B: G.22, W.23, D.24, V.25, Y.194
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:G.22, B:D.24
EDO.21: 3 residues within 4Å:- Chain C: A.14, G.23, A.24
No protein-ligand interaction detected (PLIP)EDO.31: 4 residues within 4Å:- Chain E: D.431, G.435, V.436, A.437
No protein-ligand interaction detected (PLIP)EDO.36: 5 residues within 4Å:- Chain A: T.98
- Chain E: T.675, L.676, Q.761, A.762
2 PLIP interactions:2 interactions with chain E- Hydrogen bonds: E:L.676
- Water bridges: E:V.674
EDO.37: 4 residues within 4Å:- Chain E: R.739, Y.743, P.805, D.806
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:Y.743
EDO.38: 3 residues within 4Å:- Chain E: V.672, D.673, V.694
2 PLIP interactions:2 interactions with chain E- Hydrogen bonds: E:D.673, E:D.673
- 4 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
PEG.9: 9 residues within 4Å:- Chain B: M.278, H.279, A.326, I.327, G.328, G.329, E.348, W.352, A.370
5 PLIP interactions:5 interactions with chain B- Hydrogen bonds: B:I.327, B:G.329
- Water bridges: B:M.278, B:M.278, B:A.370
PEG.10: 3 residues within 4Å:- Chain B: D.538, G.541, R.712
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:D.538
PEG.20: 6 residues within 4Å:- Chain B: A.500, G.501, R.502
- Chain D: A.236, R.239
- Chain E: L.495
1 PLIP interactions:1 interactions with chain D- Hydrogen bonds: D:R.239
PEG.32: 5 residues within 4Å:- Chain D: P.105
- Chain E: D.587, L.641, P.644, R.645
2 PLIP interactions:2 interactions with chain E- Hydrogen bonds: E:L.641, E:R.645
- 1 x EPE: 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID(Non-functional Binders)
- 1 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Gade, P. et al., Different chemical scaffolds bind to L-phe site in Mycobacterium tuberculosis Phe-tRNA synthetase. Eur.J.Med.Chem. (2025)
- Release Date
- 2025-02-12
- Peptides
- Phenylalanine--tRNA ligase alpha subunit: AD
Phenylalanine--tRNA ligase beta subunit: BE - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AD
DB
BE
E
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.35 Å
- Oligo State
- hetero-2-2-mer
- Ligands
- 2 x AX7: 1H-benzimidazol-2-amine(Non-covalent)
- 7 x MG: MAGNESIUM ION(Non-covalent)(Non-functional Binders)
- 16 x ACT: ACETATE ION(Non-functional Binders)
- 8 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 4 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- 1 x EPE: 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID(Non-functional Binders)
- 1 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Gade, P. et al., Different chemical scaffolds bind to L-phe site in Mycobacterium tuberculosis Phe-tRNA synthetase. Eur.J.Med.Chem. (2025)
- Release Date
- 2025-02-12
- Peptides
- Phenylalanine--tRNA ligase alpha subunit: AD
Phenylalanine--tRNA ligase beta subunit: BE - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AD
DB
BE
E